Free Trial

Focus Partners Wealth Increases Stock Holdings in Exelon Co. (NASDAQ:EXC)

Exelon logo with Utilities background

Focus Partners Wealth boosted its position in Exelon Co. (NASDAQ:EXC - Free Report) by 35.2% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 39,597 shares of the company's stock after acquiring an additional 10,302 shares during the period. Focus Partners Wealth's holdings in Exelon were worth $1,523,000 at the end of the most recent reporting period.

A number of other large investors have also added to or reduced their stakes in EXC. Norges Bank purchased a new position in Exelon during the 4th quarter valued at about $479,597,000. Price T Rowe Associates Inc. MD grew its position in shares of Exelon by 37.2% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 27,618,055 shares of the company's stock worth $1,039,545,000 after buying an additional 7,483,873 shares during the last quarter. FMR LLC increased its stake in shares of Exelon by 46.9% during the fourth quarter. FMR LLC now owns 17,306,652 shares of the company's stock valued at $651,422,000 after buying an additional 5,524,103 shares during the period. JPMorgan Chase & Co. raised its holdings in shares of Exelon by 109.0% during the third quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company's stock valued at $238,608,000 after acquiring an additional 3,068,309 shares in the last quarter. Finally, Vanguard Group Inc. raised its holdings in shares of Exelon by 2.5% during the fourth quarter. Vanguard Group Inc. now owns 127,335,351 shares of the company's stock valued at $4,792,903,000 after acquiring an additional 3,064,673 shares in the last quarter. Institutional investors own 80.92% of the company's stock.

Exelon Price Performance

Shares of NASDAQ:EXC traded down $0.13 during midday trading on Tuesday, reaching $44.26. 6,025,576 shares of the company were exchanged, compared to its average volume of 7,278,799. The stock has a market cap of $44.68 billion, a PE ratio of 18.07, a price-to-earnings-growth ratio of 2.86 and a beta of 0.43. The business's fifty day moving average is $45.26 and its two-hundred day moving average is $41.62. Exelon Co. has a one year low of $34.01 and a one year high of $48.11. The company has a current ratio of 0.87, a quick ratio of 0.78 and a debt-to-equity ratio of 1.61.

Exelon (NASDAQ:EXC - Get Free Report) last issued its quarterly earnings data on Thursday, May 1st. The company reported $0.92 earnings per share for the quarter, beating analysts' consensus estimates of $0.86 by $0.06. The firm had revenue of $6.71 billion during the quarter, compared to analyst estimates of $6.30 billion. Exelon had a return on equity of 9.52% and a net margin of 10.68%. The business's quarterly revenue was up 11.1% compared to the same quarter last year. During the same quarter last year, the business posted $0.68 earnings per share. As a group, analysts predict that Exelon Co. will post 2.64 earnings per share for the current year.

Exelon Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 13th. Stockholders of record on Monday, May 12th will be issued a $0.40 dividend. The ex-dividend date is Monday, May 12th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.62%. Exelon's dividend payout ratio (DPR) is presently 59.48%.

Analyst Upgrades and Downgrades

Several analysts have commented on EXC shares. Barclays raised their price objective on shares of Exelon from $42.00 to $48.00 and gave the stock an "overweight" rating in a report on Tuesday, February 25th. Morgan Stanley increased their target price on Exelon from $46.00 to $48.00 and gave the company an "equal weight" rating in a research note on Thursday, March 20th. UBS Group upped their target price on shares of Exelon from $45.00 to $47.00 and gave the company a "neutral" rating in a research note on Friday, March 21st. Evercore ISI boosted their target price on shares of Exelon from $48.00 to $51.00 and gave the company an "in-line" rating in a research note on Friday, May 2nd. Finally, KeyCorp lowered Exelon from a "sector weight" rating to an "underweight" rating and set a $39.00 price objective for the company. in a research note on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $47.30.

Check Out Our Latest Research Report on EXC

About Exelon

(Free Report)

Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.

Read More

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs
New AI Deals Just Sent These 4 Infrastructure Stocks Soaring

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines